Ocugen And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

The Dow Jones closed lower by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Ocugen

• The Trade: Ocugen, Inc. OCGN Director Junge Zhang acquired a total 200,278 shares an average price of $0.50. To acquire these shares, it cost around $100 thousand.
• What’s Happening: Ocugen announced the pricing of its $16.5 million public offering of 30 million shares of common stock.
• What Ocugen Does: Ocugen Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19.

Flotek Industries

• The Trade: Flotek Industries, Inc. FTK Director Matthew Wilks acquired a total of 172,447 shares at an average price of $0.79. The insider spent around $136.23 thousand to buy those shares.
• What’s Happening: Flotek promoted President Ryan Ezell to CEO.
• What Flotek Industries Does: Flotek Industries Inc delivers chemistry-based technology solutions for energy, industrial, and consumer applications.

Crexendo

• The Trade: Crexendo, Inc. CXDO Director Steven G Mihaylo acquired a total of 43,700 shares at an average price of $1.87. To acquire these shares, it cost around $81.86 thousand.
• What’s Happening: Crexendo posted upbeat quarterly results.
• What Crexendo Does: Crexendo Inc is a provider of cloud communications, UCaaS, call center, collaboration services, and other cloud business services.

Check This Out: Top 5 Consumer Stocks That May Explode In June

Don’t forget to check out our premarket coverage here